<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Imaging</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Imaging</journal-id><journal-title-group><journal-title>Cancer Imaging</journal-title></journal-title-group><issn pub-type="ppub">1740-5025</issn><issn pub-type="epub">1470-7330</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4242774</article-id><article-id pub-id-type="publisher-id">1470-7330-14-S1-O26</article-id><article-id pub-id-type="doi">10.1186/1470-7330-14-S1-O26</article-id><article-categories><subj-group subj-group-type="heading"><subject>Oral Presentation</subject></subj-group></article-categories><title-group><article-title>Characterization and management of cystic pancreatic neoplasms communicating lesions (IPMN)</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Morana</surname><given-names>Giovanni</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Gazzola</surname><given-names>Matteo</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Faccinetto</surname><given-names>Alex</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Addonisio</surname><given-names>Giancarlo</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Dorigo</surname><given-names>Alberto</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>Radiological Department, General Hospital Ca&#x02019; Foncello Treviso (IT), Italy</aff><aff id="I2"><label>2</label>Radiological Department, University of Padova, Italy</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>9</day><month>10</month><year>2014</year></pub-date><volume>14</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">Proceedings of the International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</named-content><named-content content-type="supplement-sponsor">Publication charges for this supplement were funded through the International Cancer Imaging Society by support received from Siemens AG, Healthcare Sector, Imaging and Therapy Division.</named-content></supplement><fpage>O26</fpage><lpage>O26</lpage><permissions><copyright-statement>Copyright &#x000a9; 2014 Morana et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Morana et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.cancerimagingjournal.com/content/14/S1/O26"/><conference><conf-date>9-11 October 2014</conf-date><conf-name>International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</conf-name><conf-loc>Heidelberg, Germany</conf-loc></conference></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Intraductal papillary mucinous neoplasms (IPMNs) are a group of exocrine mucin-producing tumors, diagnosed at a mean age of 60 years, with a male prevalence [<xref ref-type="bibr" rid="B1">1</xref>].</p><p>Improvements in imaging techniques have led to an increasing incidental detection of IPMNs: the prevalence of incidental cystic pancreatic lesions can be observed in up to 19.6% of imaging studies [<xref ref-type="bibr" rid="B2">2</xref>].</p><p>Three types of IPMNs have been described [<xref ref-type="bibr" rid="B1">1</xref>]: the main duct type; the branch-duct type and the mixed type, which meet the criteria for both MD-IPMN and BD-IPMN, with significant differences in frequencies of malignancy in IPMNs according to the morphological types, higher for MD-type (mean 61.6%) and lower for BD-type (25.5%)(3).</p></sec><sec><title>Imaging-pathologic correlations</title><sec><title>Pathologic features</title><p>IPMNs appear with a cystic dilation of the involved segment, either main duct and branch duct. Some findings can be suggestive of the behavior of the IPMN, according to the presence of high risk stigmata or worrisome features [<xref ref-type="bibr" rid="B3">3</xref>].</p><p>High risk stigmata suggest the high possibility that the lesion is malignant, thus requiring resection if the patient is surgically fit: main duct diameter &#x0003e; 10 mm for MD-IPMN, the presence of solid enhancing nodules within the cyst in BD-IPMN, or obstructive jaundice in presence of a cystic lesion of the pancreatic head.</p><p>Worrisome features suggest the possibility that the lesion could evolve as malignant, thus requiring further workup by EUS, to better risk-stratify the lesion, and a strict follow-up: cyst &#x0003e; 3 cm, thickened enhanced cyst walls, MPD size of 5-9 mm, non-enhancing mural nodules, abrupt change in the MPD caliber with distal pancreatic atrophy, and lymphadenopathy.</p></sec><sec><title>Imaging features</title><p>MR with MRCP has the highest capacity to assess the presence of communication with main pancreatic duct, with a sensitivity of 91.4-100% [<xref ref-type="bibr" rid="B4">4</xref>].</p><p>The proliferating nodule is characterized by the capacity to enhance after contrast media administration, which can be appreciated with all imaging technique (CEUS; CT; MRI), after administration of contrast media.</p><p>In case of IPMN, MDCT has a sensitivity of 70% in the diagnosis of benignity vs malignancy according to some worrisome features (nodules, main pancreatic duct &#x0003e; 10 mm, thick septa, calcifications) [<xref ref-type="bibr" rid="B5">5</xref>].</p><p>MR with MRCP has a sensitivity, specificity and accuracy of 70%, 92% and 80%, respectively in the diagnosis of benignity vs malignancy according to some worrisome features (nodules, main pancreatic duct &#x0003e; 10 mm, thick septa, calcifications)[<xref ref-type="bibr" rid="B5">5</xref>].</p></sec></sec><sec><title>Management</title><p>International consensus guidelines [<xref ref-type="bibr" rid="B3">3</xref>] recommend resection in presence of high-risk stigmata, while in presence of &#x0201c;worrisome features&#x0201d; the lesion should be evaluated by EUS to further risk-stratify the lesion. Age, status of the patient can have influence on the decision management.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Age, clinical, laboratory and imaging findings are accurate in stratifying these lesions, and imaging plays a pivotal role in their management.</p></sec></body><back><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Saini</surname><given-names>S</given-names></name><name><surname>Sahani</surname><given-names>D</given-names></name><name><surname>Hahn</surname><given-names>PF</given-names></name><name><surname>Mueller</surname><given-names>PR</given-names></name><name><surname>Auh</surname><given-names>YH</given-names></name><article-title>Imaging diagnosis of cystic pancreatic lesions: pseudocyst versus nonpseudocyst</article-title><source>Radiographics</source><year>2005</year><volume>25</volume><issue>3</issue><fpage>671</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1148/rg.253045104</pub-id><pub-id pub-id-type="pmid">15888617</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>XM</given-names></name><name><surname>Mitchell</surname><given-names>DG</given-names></name><name><surname>Dohke</surname><given-names>M</given-names></name><name><surname>Holland</surname><given-names>GA</given-names></name><name><surname>Parker</surname><given-names>L</given-names></name><article-title>Pancreatic cysts: depiction on single-shot fast spin-echo MR images</article-title><source>Radiology</source><year>2002</year><volume>223</volume><issue>2</issue><fpage>547</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1148/radiol.2232010815</pub-id><pub-id pub-id-type="pmid">11997566</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Fernandez-del Castillo</surname><given-names>C</given-names></name><name><surname>Adsay</surname><given-names>V</given-names></name><name><surname>Chari</surname><given-names>S</given-names></name><name><surname>Falconi</surname><given-names>M</given-names></name><name><surname>Jang</surname><given-names>JY</given-names></name><etal/><article-title>International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas</article-title><source>Pancreatology</source><year>2012</year><volume>12</volume><issue>3</issue><fpage>183</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/j.pan.2012.04.004</pub-id><pub-id pub-id-type="pmid">22687371</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Sainani</surname><given-names>NI</given-names></name><name><surname>Saokar</surname><given-names>A</given-names></name><name><surname>Deshpande</surname><given-names>V</given-names></name><name><surname>Fernandez-del Castillo</surname><given-names>C</given-names></name><name><surname>Hahn</surname><given-names>P</given-names></name><name><surname>Sahani</surname><given-names>DV</given-names></name><article-title>Comparative performance of MDCT and MRI with MR cholangiopancreatography in characterizing small pancreatic cysts</article-title><source>AJR Am J Roentgenol</source><year>2009</year><volume>193</volume><issue>3</issue><fpage>722</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.2214/AJR.08.1253</pub-id><pub-id pub-id-type="pmid">19696285</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Sahani</surname><given-names>DV</given-names></name><name><surname>Kadavigere</surname><given-names>R</given-names></name><name><surname>Blake</surname><given-names>M</given-names></name><name><surname>Fernandez-Del Castillo</surname><given-names>C</given-names></name><name><surname>Lauwers</surname><given-names>GY</given-names></name><name><surname>Hahn</surname><given-names>PF</given-names></name><article-title>Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP</article-title><source>Radiology</source><year>2006</year><volume>238</volume><issue>2</issue><fpage>560</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1148/radiol.2382041463</pub-id><pub-id pub-id-type="pmid">16436817</pub-id></mixed-citation></ref></ref-list></back></article>